Skip to main content

Table 3 Patients with height below/within normal ranges by indication

From: Noonan syndrome and Turner syndrome patients respond similarly to 4 years’ growth-hormone therapy: longitudinal analysis of growth-hormone-naïve patients enrolled in the NordiNet® International Outcome Study and the ANSWER Program

 

Noonan syndrome patients

Turner syndrome patients

 

HSDS < –2

HSDS > –2

HSDS < –2

HSDS > –2

n (%)

n (%)

n (%)

n (%)

Baseline

24 (80)

6 (20)

240 (82)

54 (18)

Year 1

16 (53)

14 (47)

166 (56)

128 (44)

Year 2

15 (50)

15 (50)

127 (43)

167 (57)

Year 3

9 (30)

21 (70)

113 (38)

181 (62)

Year 4

7 (23)

23 (77)

102 (35)

192 (65)

  1. HSDS Height standard deviation score